First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors GBX 1,581.10 +27.70 (+1.78%) (As of 11/20/2024 09:21 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines FBT vs. SGE, AVV, AVST, SOPH, PRSM, KAPE, TRST, KNOS, GBG, and LTGShould you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include The Sage Group (SGE), AVEVA Group (AVV), Avast (AVST), Sophos Group plc (SOPH.L) (SOPH), Blue Prism Group (PRSM), Kape Technologies (KAPE), Trustpilot Group (TRST), Kainos Group (KNOS), GB Group (GBG), and Learning Technologies Group (LTG). These companies are all part of the "software - application" industry. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs. The Sage Group AVEVA Group Avast Sophos Group plc (SOPH.L) Blue Prism Group Kape Technologies Trustpilot Group Kainos Group GB Group Learning Technologies Group The Sage Group (LON:SGE) and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, community ranking, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations. Does the MarketBeat Community prefer SGE or FBT? The Sage Group received 452 more outperform votes than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation when rated by MarketBeat users. However, 66.67% of users gave First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation an outperform vote while only 45.06% of users gave The Sage Group an outperform vote. CompanyUnderperformOutperformThe Sage GroupOutperform Votes52445.06% Underperform Votes63954.94% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationOutperform Votes7266.67% Underperform Votes3633.33% Do analysts recommend SGE or FBT? The Sage Group currently has a consensus target price of GBX 1,173, suggesting a potential downside of 7.86%. Given The Sage Group's stronger consensus rating and higher possible upside, analysts plainly believe The Sage Group is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Sage Group 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals believe in SGE or FBT? 67.0% of The Sage Group shares are held by institutional investors. 1.1% of The Sage Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer SGE or FBT? In the previous week, The Sage Group had 7 more articles in the media than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. MarketBeat recorded 7 mentions for The Sage Group and 0 mentions for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. The Sage Group's average media sentiment score of 1.16 beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's score of 0.00 indicating that The Sage Group is being referred to more favorably in the media. Company Overall Sentiment The Sage Group Positive First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Neutral Is SGE or FBT more profitable? The Sage Group has a net margin of 11.87% compared to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's net margin of 0.00%. The Sage Group's return on equity of 22.31% beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity.Company Net Margins Return on Equity Return on Assets The Sage Group11.87% 22.31% 7.58% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation N/A N/A N/A Which has higher valuation and earnings, SGE or FBT? The Sage Group has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than The Sage Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThe Sage Group£2.25B5.64£267M£0.264,896.15First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation£870.31K5,368.12N/A-£1.10-1,437.36 SummaryThe Sage Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 14 of the 16 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBT vs. The Competition Export to ExcelMetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON ExchangeMarket Cap£4.67B£2.84B£24.07B£1.39BDividend YieldN/A3.06%2.76%11.73%P/E Ratio-1,437.36815.81220.901,551.34Price / Sales5,368.124,635.813,397.91209,137.85Price / Cash3.5417.1032.7032.93Price / Book832.1613.036.812.80Net IncomeN/A£29.91M£658.94M£152.70M7 Day Performance-5.09%-0.36%0.18%-0.51%1 Month PerformanceN/A0.75%0.76%7.08%1 Year Performance15.87%20.48%18.84%91.78% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBTFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AGBX 1,581.10+1.8%N/AN/A£4.67B£870,310.00-1,437.3620SGEThe Sage Group0.6809 of 5 starsGBX 1,273+0.3%GBX 1,173-7.9%+28.3%£12.68B£2.25B4,882.6911,326Dividend IncreaseNews CoveragePositive NewsHigh Trading VolumeAVVAVEVA GroupN/AGBX 3,219+9,900.0%N/AN/A£9.72B£1.26B-154.766,250Gap UpAVSTAvastN/AGBX 716.60-0.5%N/A+0.0%£7.49B£940.10M3,115.651,800High Trading VolumeSOPHSophos Group plc (SOPH.L)N/AGBX 580.40+1.0%N/A+0.0%£2.99B£726.90M341.41520PRSMBlue Prism GroupN/AGBX 1,274flatN/AN/A£1.24B£167.30M-23.681,025High Trading VolumeKAPEKape TechnologiesN/AGBX 285+0.7%N/A+0.0%£1.22B£623.48M1,900.00850Gap DownTRSTTrustpilot Group0.714 of 5 starsGBX 281.50+0.5%GBX 260-7.6%+129.9%£1.17B£191.59M9,333.33820KNOSKainos Group2.4272 of 5 starsGBX 812-0.2%GBX 1,200+47.8%-17.8%£1.02B£382.39M2,076.032,953GBGGB Group0.5089 of 5 starsGBX 353.20-0.1%GBX 356.67+1.0%+34.1%£890.49M£277.32M-1,860.001,183Analyst ForecastGap DownLTGLearning Technologies Group1.6957 of 5 starsGBX 89.90-2.3%GBX 90+0.1%+19.7%£712.00M£528.05M2,300.005,001 Related Companies and Tools Related Companies The Sage Group Competitors AVEVA Group Competitors Avast Competitors Sophos Group plc (SOPH.L) Competitors Blue Prism Group Competitors Kape Technologies Competitors Trustpilot Group Competitors Kainos Group Competitors GB Group Competitors Learning Technologies Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:FBT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
